Navigation Links
First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder

Treatment Benefits Were Maintained for at Least 24 Weeks, According to Report Published in The Journal of Urology

LONDON, May 15, 2007 /PRNewswire/ -- Researchers from Guy's Hospital and King's College London School of Medicine have announced the results from the first randomized, double-blind, placebo-controlled study evaluating botulinum toxin type A (BTX-A, BOTOX(R)) as a treatment for idiopathic detrusor overactivity (IDO) in patients with symptoms of overactive bladder (OAB). The trial results which are published in the June 2007 issue of The Journal of Urology show that BTX-A is safe and effective for this use and that the beneficial effects -- including improved quality of life -- persist for at least 24 weeks.

"The findings of this study are important because there is a need for new treatments for OAB patients who have unsatisfactory responses to therapies which are currently available and who do not want to consider invasive surgery," said Mr. Arun Sahai, who was a principal investigator of the study during his time as a research fellow at Guy's Hospital, London. "This study demonstrated that botulinum toxin type A may be a promising treatment option for patients with OAB symptoms."

OAB is characterized by feelings of urgency to urinate, with or without incontinence, and is usually accompanied by increased urination frequency and nocturia (excessive urination at night). A large proportion of OAB patients have what is referred to as idiopathic detrusor overactivity or IDO -- excessive activity of the muscles that contract the bladder, due to an unknown cause -- and are treated with drugs called anticholinergics (e.g., tolterodine). However, many OAB patients discontinue medication due to insufficient relief of symptoms or intolerable side effects that can include dry mouth, dry eyes, constipation and headache.

"This study showed that this treatment had real benefits for patients for
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:5/24/2013)... , May 24, 2013  Regulatory and ... forefront of many organizations, priority list. ... device sectors understand a strong Medical Affairs ... in clinical development, market education , and ... create a vital bridge between an organization and ...
(Date:5/24/2013)... N.J. , May 24, 2013  BD (Becton, Dickinson ... medical technology company, announced today that it will present at ... on Thursday, May 30, 2013, at 10:40 a.m. (ET). ... accessed from the BD corporate website at www.bd.com/investors ... 2013.    About BD BD is ...
(Date:5/24/2013)... 24, 2013 /PRNewswire-iReach/ -- Phoenix Houses of ... services organization, is hosting its tenth annual "Triumph For ... June 6, 2013.  More than 300 people are expected ... adolescent residential treatment centers, family therapy, and prevention programs ... accomplishments have positive influences on the health and welfare of ...
Breaking Medicine Technology:Building Medical Affairs Capabilities to Ensure Organizational Success across Key Operational Areas 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3
(Date:5/25/2013)... Prairie Living at Chautauqua , a BMA ... Cross Blood Drive from 1:30 to 5:30 p.m. on ... at 955 Villa Ct. in Carbondale, Illinois, serves older ... need some help to maintain their independence.. , "Come ... Frey, Director of Marketing for Prairie Living. , For ...
(Date:5/25/2013)... 2013 For college students, few ... Increasingly, they are turning to prescription stimulants like ... For more on this, go to http://www.sciencedaily.com/releases/2013/05/130501145151.htm ... warns that students who pick up Adderall, “just ... for developing a physical and psychological dependency. While ...
(Date:5/25/2013)... Ayurveda is the traditional medicine of India. Ayurveda ... medical science, its scope enters into the realms of the ... that disease is the end result of living out of ... one must discover where we are living out of harmony ... into perfect harmony. , The Foundations course in Mexico ( ...
(Date:5/25/2013)... Ayurveda is the traditional medicine of India. Translated from ... a medical science, its scope enters into the realms of ... is that disease is the end result of living out ... to re-establish optimal health, we must discover where we are ... which brings us back into harmony. , The California College ...
(Date:5/25/2013)... 2013 Superior Magnetics for Pain Free ... seconds for arthritis, tendinitis and bursitis , Pain Free ... products announced a magnetic bracelet so strong ... pain relief is demonstrated at fairs and festivals. This ... magnets and has customers often report pain relief in ...
Breaking Medicine News(10 mins):Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California 2Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2Health News:Magnetic bracelet relieves pain in seconds announces Superior Magnetics 2
... Del., Nov. 2 Staff and board,members of Delaware ... Lloyd, MSN, RN, for 20 years of service at ... has guided Delaware Hospice from a fledgling,grassroots organization to ... community support with quality and compassion., In 1987, ...
... Barr,Pharmaceuticals, Inc. (NYSE: BRL ) today confirmed ... challenge of the patents listed by,Novartis Pharmaceuticals Corporation ... capsules, 10mg, 20mg, 30mg,and 40mg. Barr filed ... IV certification for a generic Ritalin LA product ...
... SOUTH PORTLAND, Maine, Nov. 2 Small employers ... much larger businesses. Anthem,Blue Cross and Blue Shield ... for small businesses (50 or fewer employees) under ... health insurance,choices than have ever been available for ...
... Urology; Initiated for ... Dermatology and OB/GYN, ... force in measuring the impact of pharmaceutical promotion on,physicians, prescribing ... networks in alignment with emerging market,trends and rising client demand. ...
... Mass., Nov. 2 Pressure,BioSciences, Inc. (Nasdaq: PBIO ... President, and CEO, will present a corporate,overview at The ... New York City on Monday, November 5, 2007 at ... The New York Palace Hotel, New York,City. The Company,s ...
... PXS; Nasdaq: PXSL) today announced moves to expand its ... construction of a new,state of the art facility at ... the fourth quarter of 2008,Pharmaxis may lease the 7,000 ... 15 years with two options to renew of five ...
Cached Medicine News:Health News:Delaware Hospice Honors President and CEO Susan D. Lloyd, MSN, RN 2Health News:Delaware Hospice Honors President and CEO Susan D. Lloyd, MSN, RN 3Health News:Barr Confirms Patent Challenge of Ritalin(R) LA 2Health News:Barr Confirms Patent Challenge of Ritalin(R) LA 3Health News:Anthem Introduces New Insurance Options for Small Business 2Health News:ImpactRx Announces Expansion and Addition of Physician Information Networks 2Health News:ImpactRx Announces Expansion and Addition of Physician Information Networks 3Health News:Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th 2Health News:Pharmaxis to Expand Manufacturing Capacity 2
The 5524-7.5 linear transducer is a high frequency transducer dedicated to superficial and vascular imaging....
The 5539-7.5 linear transducer is a high frequency transducer dedicated to superficial and vascular imaging....
HST, versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
Scan internal organs percutaneously while eliminating side lobe artifact....
Medicine Products: